TrialThe oncologist2021

Analysis of the Role of Plasma 25-Hydroxyvitamin D Levels in Survival Outcomes in Patients from the Phase III MPACT Trial of Metastatic Pancreatic Cancer.

Daniel D Von Hoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.